Together, these findings identify sodium acetate as a potent senomorphic agent that mitigates PAA-induced endothelial dysfunction through a mechanism distinct from PAA’s mechanism in HDAC4-regulated SASP activation. Here, HDAC4 is linked to endothelial dysfunction.